Kings Path Partners »

Eton Pharmaceuticals shares owned by Kings Path Partners

Quarter-by-quarter ownership of Eton Pharmaceuticals (ETON) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Eton Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eton Pharmaceuticals held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eton Pharmaceuticals by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2026-09-30 $181k 3.5k 51.49

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Dimensional Etf Trust Core Fixe In Etf (DFCF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Dimensional Etf Trust Us Targeted Vlu
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Glob Co Plus Etf (DFGP)
Vanguard Malvern Fds Core Bd Etf (VCRB)
American Centy Etf Tr Avantis Emgmkt (AVEM)

View all positions for Kings Path Partners

Top funds holding Eton Pharmaceuticals

Opaleye Management
EcoR1 Capital
BlackRock
Nantahala Capital Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Oberweis Asset Management
National Philanthropic Trust
Westside Investment Management
Nuveen
Bnp Paribas Arbitrage, Snc
Woodline Partners
Thompson, Siegel, & Walmsley
Northern Trust

View all funds holding Eton Pharmaceuticals